title: Investigation of the efficacy of a genetically-stabile live Salmonella typhimurium vaccine for use in swine.
abstract: Hybrid swine (Landrace x Pietrain) aged 3-4 weeks were immunized twice at an interval of 3 weeks solely by the oral route and by the oral/parenteral route to evaluate the efficacy of a live S. Typhimurium vaccine. In each experiment a control group was run without vaccination. The animals were challenged at the age of 8-10 weeks by oral test infection with a labelled S. Typhimurium DT 104 strain. An ELISA was used to establish the presence of antibodies to S. Typhimurium in serum samples, coupled with clinical investigation. The presence of the challenge strain in the ileal and caecal mucosa and in the ileocolic lymph nodes was investigated quantitatively using the Koch plating method to determine the degree of colonization of those organs at the time of slaughter. The clinical course of disease was used to assess the success of vaccination. However, it was not possible to trigger, in a reproducible manner, clinical signs of disease in unvaccinated animals through infection. The vaccinated animals had a significantly lower (p < 0.05) colonization of the ileal and caecal mucosa than the unvaccinated animals. This was also seen to a lesser degree for the ileocolic lymph nodes.
authors.affiliation: Impfstoffwerk Dessau-Tornau GmbH, PSF 214, Rosslau, Germany. sven.springer@idt-direct.de
authors.forename: S
authors.initials: S
authors.lastname: Springer
authors.forename: T
authors.initials: T
authors.lastname: Lindner
authors.forename: G
authors.initials: G
authors.lastname: Steinbach
authors.forename: H J
authors.initials: HJ
authors.lastname: Selbitz
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D016022:Case-Control Studies; D015169:Colony Count, Microbial; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000662:veterinary; D005260:Female; D007413:Intestinal Mucosa / Q000382:microbiology; D008198:Lymph Nodes / Q000382:microbiology; D008297:Male; D012481:Salmonella Infections, Animal / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D022562:Salmonella Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000592:standards; D012486:Salmonella typhimurium / Q000276:immunology*; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D016896:Treatment Outcome; D014611:Vaccination / Q000592:standards / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology / Q000592:standards
chemical_list: D000907:Antibodies, Bacterial; D022562:Salmonella Vaccines; D014613:Vaccines, Attenuated